Mengchao Hepatpbiliary Hospital of Fujian Medical University
Welcome,         Profile    Billing    Logout  
 1 Trial 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zheng, Ling
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
NCT05345964: Phase I Study of GST-HG151 Tablets in Healthy Volunteers

Recruiting
1
112
RoW
GST-HG151, Placebo
Fujian Cosunter Pharmaceutical Co. Ltd
Healthy Volunteers
03/23
05/23

Download Options